Playlist

Turkmen Schoolchildren Set World Records in Mental Arithmetic

22 Aug. 04:39

On August 21, Ashgabat hosted a major mental arithmetic competition for schoolchildren as part of the international exhibition "Kids Expo: Everything for Children." Around 120 participants aged 6 to 14 from across the country took part in the intellectual marathon.

The event was organized by the Ministry of Education of Turkmenistan, the Makhtumkuli Youth Organization, the Chamber of Commerce and Industry, and the educational center “Kämil bilim.” One of the honorary guests was Melik Duyar, an international judge and founder of “Mega Hafyza,” as well as a co-founder of the World Federation of Intellectual Sports MEMORIAD.

During the 45-minute competition, students showcased lightning-fast calculations and impressive focus. The branch of “Kämil bilim” from Turkmenabat claimed the highest number of medals — 12. The Ashgabat center won 7 medals, Balkanabat — 2, and one medal each went to representatives from Mary and Bayramaly.

Three young talents made the nation proud by setting world records:

  • Aly Orashov (Balkanabat) — in the Quick Flash Anzan category, instantly summing 150 alternating two-digit numbers at a speed of 0.3 seconds.

  • Rovach Begenzhov (Turkmenabat) — for the fastest mental addition of 100 randomly ordered single-digit numbers.

  • Mekan Batyrov (Balkanabat) — for correctly multiplying eight-digit numbers by eight-digit numbers 10 times in a row from memory

The gifted students received commemorative gifts, certificates, and official recognition from the World Federation of Intellectual Sports MEMORIAD. Their outstanding achievements have become a source of national pride and are a testament to the remarkable intellectual potential of Turkmenistan's younger generation.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌